Compare GNLX & RFIL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | GNLX | RFIL |
|---|---|---|
| Founded | 2001 | 1979 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Electrical Products |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 113.6M | 99.5M |
| IPO Year | 2022 | 1996 |
| Metric | GNLX | RFIL |
|---|---|---|
| Price | $2.57 | $10.91 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 5 | 1 |
| Target Price | ★ $19.80 | $11.25 |
| AVG Volume (30 Days) | 151.5K | ★ 292.3K |
| Earning Date | 05-05-2026 | 03-16-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 9.47 | ★ 101.59 |
| EPS | N/A | ★ N/A |
| Revenue | $8,000.00 | ★ $55,325,000.00 |
| Revenue This Year | N/A | $7.07 |
| Revenue Next Year | N/A | $8.97 |
| P/E Ratio | ★ N/A | $1,203.00 |
| Revenue Growth | N/A | ★ 10.22 |
| 52 Week Low | $1.99 | $3.39 |
| 52 Week High | $8.54 | $13.54 |
| Indicator | GNLX | RFIL |
|---|---|---|
| Relative Strength Index (RSI) | 48.69 | 50.65 |
| Support Level | $2.54 | $6.32 |
| Resistance Level | $3.00 | $12.69 |
| Average True Range (ATR) | 0.16 | 1.38 |
| MACD | 0.01 | -0.08 |
| Stochastic Oscillator | 56.00 | 35.63 |
Genelux Corp is a clinical-stage biopharmaceutical company. The company focuses on developing next-generation oncolytic viral immunotherapies for patients suffering from aggressive or difficult-to-treat solid tumor types. Its pipeline products include Olvi-Vec (olvimulogene nanivacirepvec), Lung, and Pancreatic Cancer.
RF Industries Ltd is engaged in the design, manufacture, and marketing of interconnect products and systems, including coaxial and specialty cables, fiber optic cables and connectors, and electrical and electronic specialty cables. The company has one operating segment. The company operates in Canada, Germany, China, the USA, and the United Kingdom, and Others.